FDA Inspection 1217675 — Munson Medical Center
The FDA completed an inspection of Munson Medical Center on August 3, 2023 in Traverse City, MI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 3, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Traverse City, MI (United States)